Hairy Cell Leukemia Market

Hairy Cell Leukemia (HCL) is an uncommon hematologic malignancy characterized by pancytopenia and marked susceptibility to infection. The condition is named after the excess B cells which look ‘hairy’ under a microscope.

Hairy Cell Leukemia Market Key Facts
The total incident population of Hairy Cell Leukemia in the 7 major markets was found to be 2,364 in 2017.
According to the Hairy Cell Leukemia Foundation, the median age at diagnosis of Hairy Cell Leukemia is 58 years and the disease is four-times more common in men than in women.
Around 90 out of every 100 (90%) will survive their leukaemia for 5 years or more after they are diagnosed [Cancer Research UK].
HCL affects about 6,000 persons in the United States. Approximately, 600-800 new cases are diagnosed each year. Most of the affected individuals are males of 50 years of age or older [National Organization for Rare Disorders].

For more details visit:
https://www.delveinsight.com/report-store/hairy-cell-leukemia-hcl-market